This federal contract award is for RAPID ACCELERATION OF DIAGNOSTICS (RADX) CLINICAL EVALUATION SERVICES, provided by the National Collegiate Inventors & Innovators Alliance, Inc. (doing business as Venturewell), a non-profit organization based in Hadley, Massachusetts. The $1,102,384.62 firm fixed-price delivery order was awarded on March 5, 2021 by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH).
Venturewell has extensive experience managing federal contracts and grants focused on advancing biomedical and healthcare technologies, including substantial work under the NIH's Rapid Acceleration of Diagnostics (RADx) initiative to clinically evaluate COVID-19 diagnostic tests and other disease diagnostics. The award does not have a set-aside designation. Venturewell also holds several large indefinite delivery contracts (IDCs) with NIH agencies to provide a range of innovation support services, including management of the RADx award program and operation of commercialization centers for public health priorities.
Generated 12/13/24, 9:39 AM